From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Children ≤18 years | Adults > 18 years | |||||||
---|---|---|---|---|---|---|---|---|
Health | Productivity | Social | Total | Health | Productivity | Social | Total | |
Mild (GMFCS level I/II) | 1,279 | 0 | 51,146 | 52,425 | 146 | 16,991 | 23,905 | 41,042 |
Moderate (GMFCS level III) | 2,895 | 0 | 77,179 | 80,074 | 331 | 25,653 | 36,072 | 62,056 |
Severe (GMFCS level IV/V) | 3,100 | 0 | 87,278 | 90,378 | 355 | 28,992 | 40,792 | 70,139 |